The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...

Bicara Therapeutics shows potential to reshape cancer care with ficerafusp alfa and robust funding post-IPO. Find out why ...

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck ...

The FDA granted regenerative medicine advanced therapy designation to iltamciocel for patients with oropharyngeal dysphagia ...

Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery, is pleased to announce the inclusion of the first patient in its phase I ...

A South Carolina native and two-time Super Bowl champion celebrated a life win recently. Jim Stuckey is cancer-free after an ...

Beth Riehle, a cancer patient, is using social media to show that life can still be full and meaningful, even after a ...

Researchers at the University of Kentucky have introduced a novel microscopy technique that could revolutionize cancer research by providing an ...

An Okanagan man is suing Interior Health and several doctors for malpractice after a cancer misdiagnosis delayed care and ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...

Five-year data from the KEYNOTE-048 trial support the use of pembrolizumab and pembrolizumab-chemotherapy as standards of care, researchers wrote.